Clinical trial
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative…
NCT00222794 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00222794 |
|---|---|
| Title | A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia |
| Official title | A Randomized, Parallel Group, Double Blind, Placebo Controlled, Clinical Trial of Augmentation With Atomoxetine for the Treatment of Negative Symptoms in Patients With Schizophrenia and Schizoaffective Disorder |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Atomoxetine (Strattera) |
| Enrollment | 66 |
| Start date | Nov 1, 2003 |
| Completion | Jul 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 31, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: